Gilead Sciences | 판매 매출 총 이익



Gross Profit On Sales 변화 날짜
AbbVie USD 9.34B 1.36B 2025-03
Agios Pharmaceuticals USD 10.75M 3.11M 2025-06
ALKERMES USD 257.77M 462K 2025-06
Alnylam Pharmaceuticals USD 630.74M 107.59M 2025-06
Amgen USD 6.17B 624M 2025-06
Biogen USD 2.04B 238.8M 2025-06
BioMarin Pharmaceutical USD 670.47M 76.89M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Eli Lilly USD 13.11B 2.61B 2025-06
Gilead Sciences USD 5.58B 453M 2025-06
GlaxoSmithKline GBP 5.82B 229M 2025-06
Glaxosmithkline GBP 5.6B 94M 2024-12
Incyte USD 1.14B 151.67M 2025-06
J&J USD 14.6B 816M 2025-03
Merck USD 12.99B 224M 2025-06
Moderna USD 18M 1000K 2025-06
Neurocrine Biosciences USD 676.2M 112.8M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Pfizer USD 10.88B 248M 2025-06
PTC Therapeutics USD 163.39M 999.84M 2025-06
Regeneron Pharmaceuticals USD 3.15B 581M 2025-06
Sanofi EUR 7.74B 26M 2025-06
Sarepta Therapeutics USD 457.87M 149.43M 2025-06
United Therapeutics USD 711M 9.1M 2025-06
Vertex Pharmaceuticals USD 2.56B 150M 2025-06


Gilead Sciences 판매 매출 총 이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Aug 2025.